Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-035085

CEO and CFO bought 1,500 shares at $13.62 ($20,430)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2026-07-27 Purchase +1,500 $13.62 $20,430 5,609,202 D
Open-market purchases · 1,500 sh · avg $13.62 · $20,430
Loading xslF345X06/ownership.xml…